Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma

CONTEXT: Neoadjuvant chemotherapy is increasingly used in borderline resectable and locally advanced pancreatic cancer to facilitate surgical resection. OBJECTIVE: To compare progression free survival and overall survival in patients receiving neoadjuvant FOLFIRINOX with those receiving gemcitabine/...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JOP
Hlavní autoři: Chapman, Brandon C, Gleisner, Ana, Rigg, Devin, Messersmith, Wells, Paniccia, Alessandro, Meguid, Cheryl, Gajdos, Csaba, McCarter, Martin D, Schulick, Richard D, Edil, Barish H
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018015/
https://ncbi.nlm.nih.gov/pubmed/29950957
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky